Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation

被引:15
作者
Kelley Weinfurtner
Kimberly Forde
机构
[1] Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
[2] Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
关键词
Arterial hypoxemia with elevated A-a gradient; Hepatopulmonary syndrome; Intravascular pulmonary dilation; Liver transplant evaluation; Portopulmonary hypertension; Pulmonary hypertension medical therapy;
D O I
10.1007/s11901-020-00532-y
中图分类号
学科分类号
摘要
Purpose of Review: Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PoPH) are both pulmonary vascular complications of advanced liver disease; however, these syndromes have distinct pathophysiology, clinical implications, and management. Recent Findings: While both conditions are associated with portal hypertension, HPS results from diffuse pulmonary capillary vasodilation and PoPH results from vasoconstriction and vascular remodeling of pulmonary arteries. In HPS, no medical therapies clearly improve outcomes; however, patients have excellent post-LT outcomes with near uniform reversal of hypoxemia. In PoPH, several medical therapies used in idiopathic pulmonary hypertension have been shown improve pulmonary hemodynamics, symptoms, and potentially LT outcomes; however, further study is needed to determine best treatment regimens, long-term outcomes on medical therapy, and role of LT. Summary: While HPS results in severe hypoxemia that is usually reversible by LT, PoPH patients develop progressive pulmonary hypertension that may improve with medical therapy. © Springer Science+Business Media, LLC, part of Springer Nature 2020.
引用
收藏
页码:174 / 185
页数:11
相关论文
共 118 条
[1]  
Rodriguez-Roisin R., Krowka M.J., Herve P., Fallon M.B., Barbera J.A., Caneva J.O., Et al., Pulmonary-hepatic vascular disorders (PHD), Eur Respir J, 24, 5, pp. 861-880, (2004)
[2]  
De B.K., Sen S., Biswas P.K., Mandal S.K., Das D., Das U., Et al., Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression, Gastroenterology, 122, 4, pp. 897-903, (2002)
[3]  
Regev A., Yeshurun M., Rodriguez M., Sagie A., Neff G.W., Molina E.G., Schiff E.R., Transient hepatopulmonary syndrome in a patient with acute hepatitis a, J Viral Hepat, 8, 1, pp. 83-86, (2001)
[4]  
Teuber G., Teupe C., Dietrich C.F., Caspary W.F., Buhl R., Zeuzem S., Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis, Eur J Intern Med, 13, 5, pp. 311-318, (2002)
[5]  
Baiges A., Turon F., Simon-Talero M., Tasayco S., Bueno J., Zekrini K., Plessier A., Franchi-Abella S., Guerin F., Mukund A., Eapen C.E., Goel A., Shyamkumar N.K., Coenen S., Gottardi A., Majumdar A., Onali S., Shukla A., Carrilho F.J., Nacif L., Primignani M., Tosetti G., Mura V., Nevens F., Witters P., Tripathi D., Tellez L., Martinez J., Alvarez-Navascues C., Fraile Lopez M.L., Procopet B., Piscaglia F., Koning B., Llop E., Romero-Cristobal M., Tjwa E., Monescillo-Francia A., Senzolo M., Per
[6]  
Rodriguez-Roisin R., Krowka M.J., Hepatopulmonary syndrome-a liver-induced lung vascular disorder, N Engl J Med, 458, 22, pp. 2378-2387, (2008)
[7]  
Berthelot P., Walker J.G., Sherlock S., Reid L., Arterial changes in the lungs in cirrhosis of the liver — lung spider nevi, N Engl J Med, 274, 6, pp. 291-298, (1966)
[8]  
Lejealle C., Paradis V., Bruno O., de Raucourt E., Francoz C., Soubrane O., Et al., Evidence for an association between intrahepatic vascular changes and the development of hepatopulmonary syndrome, Chest, 155, 1, pp. 123-136, (2011)
[9]  
New Evidence that There are Vascular Changes within the Liver Itself as Well as Pulmonary and Splanchnic Vascular Changes in HPS
[10]  
Borkar V.V., Poddar U., Kapoor A., Ns S., Srivastava A., Yachha S.K., Hepatopulmonary syndrome in children: a comparative study of non-cirrhotic vs. cirrhotic portal hypertension, Liver Int, 35, 6, pp. 1665-1672, (2015)